Phentermine News and Research

RSS
Phentermine is a drug that decreases your appetite.
MGH investigators report that medication could augment benefits of bariatric surgery

MGH investigators report that medication could augment benefits of bariatric surgery

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

FDA approves two drugs for long-term weight loss

FDA approves two drugs for long-term weight loss

TSRI scientists discover viable strategy for weight loss in people

TSRI scientists discover viable strategy for weight loss in people

Study supports topiramate as promising medication to treat addiction

Study supports topiramate as promising medication to treat addiction

Eisai submits BELVIQ NDS with Health Canada

Eisai submits BELVIQ NDS with Health Canada

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

ScinoPharm to offer commercial manufacturing of topiramate API for VIVUS' Qsymia

ScinoPharm to offer commercial manufacturing of topiramate API for VIVUS' Qsymia

Vivus receives FDA approval for Qsymia to manage chronic weight

Vivus receives FDA approval for Qsymia to manage chronic weight

Two-drug combo increases diabetes patients’ goal achievement

Two-drug combo increases diabetes patients’ goal achievement

Experimental medication helps overweight patients with diabetes shed pounds

Experimental medication helps overweight patients with diabetes shed pounds

Weight loss pill Qnexa wins panel vote and awaits approval

Weight loss pill Qnexa wins panel vote and awaits approval

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

FDA EMDAC recommends approval of VIVUS' Qnexa for obesity

FDA EMDAC recommends approval of VIVUS' Qnexa for obesity

FDA to review rejected weight loss drug Qnexa

FDA to review rejected weight loss drug Qnexa

FDA approves Lannett's supplemental ANDA for Phentermine HCl to treat obesity

FDA approves Lannett's supplemental ANDA for Phentermine HCl to treat obesity

FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity

FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity

VIVUS announces results of Qnexa clinical study on cardiometabolic disease

VIVUS announces results of Qnexa clinical study on cardiometabolic disease

FDA accepts VIVUS' Qnexa NDA for filing and review

FDA accepts VIVUS' Qnexa NDA for filing and review

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.